MEDBED POD Trademark

Trademark Overview


On Wednesday, November 8, 2023, a trademark application was filed for MEDBED POD with the United States Patent and Trademark Office. The USPTO has given the MEDBED POD trademark a serial number of 98260464. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, October 3, 2024. The MEDBED POD trademark is filed in the Medical Instrument Products category with the following description:

Low frequency electromagnetic therapy apparatus
medbed pod

General Information


Serial Number98260464
Word MarkMEDBED POD
Filing DateWednesday, November 8, 2023
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, October 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesLow frequency electromagnetic therapy apparatus

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, November 8, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressPowder Spring, GA 30127

Trademark Events


Event DateEvent Description
Wednesday, November 8, 2023NEW APPLICATION ENTERED
Thursday, January 25, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 17, 2024ASSIGNED TO EXAMINER
Tuesday, June 18, 2024NON-FINAL ACTION E-MAILED
Tuesday, June 18, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 3, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, October 3, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, June 18, 2024NON-FINAL ACTION WRITTEN